NASDAQ: KALV - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Read More

Pharma Industry News

Investors eye KalVista’s $125m debt raise—Can EKTERLY commercialization justify the premium terms?

KalVista raises $125M through convertible notes due 2031 to fund EKTERLY commercialization. Find out what this financing means for biotech investors.

byPallavi Madhiraju

September 25, 2025

web analytics